FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593644105> ?p ?o ?g. }

• W2593644105 endingPage "5070" @default.
• W2593644105 startingPage "5059" @default.
• W2593644105 abstract "The β2-Adrenergic receptor (β2-AR) is associated with tumor growth and progression. However, the clinical significance of β2-AR expression in patients with non-small cell lung cancer (NSCLC) remains unclear.Three hundred twenty-eight patients with surgically resected NSCLC were retrospectively investigated. Tumor sections were stained by immunohistochemistry for assessing β2-AR and Ki-67 expression and microvessel density (MVD), which was using CD34 levels.β2-AR was positively expressed in 27% of all patients, in 29% of adenocarcinoma (AC) patients, and in 24% of non-AC patients. In AC patients, β2-AR expression was significantly correlated with lymphatic permeation (r=0.240; P<0.001), vascular invasion (r=0.239; P<0.001), and Ki-67 expression (r=0.175; P=0.009). However, this correlation was not observed in non-AC patients. Positive β2-AR expression was identified as a negative predictor for worse outcomes in AC patients, particularly in those with stage I tumors. Multivariate analysis confirmed that β2-AR expression was an independent factor for predicting poor progression-free survival in stage I AC patients (HR=2.220; 95% CI, 1.077-4.573; P=0.031).β2-AR expression is an independent prognostic factor for early-stage AC patients." @default.
• W2593644105 created "2017-03-16" @default.
• W2593644105 creator A5007784673 @default.
• W2593644105 creator A5017461232 @default.
• W2593644105 creator A5033780369 @default.
• W2593644105 creator A5053315729 @default.
• W2593644105 creator A5055462599 @default.
• W2593644105 creator A5062755674 @default.
• W2593644105 creator A5065203827 @default.
• W2593644105 creator A5078077911 @default.
• W2593644105 creator A5081222766 @default.
• W2593644105 creator A5085034288 @default.
• W2593644105 date "2016-01-01" @default.
• W2593644105 modified "2023-10-03" @default.
• W2593644105 title "Prognostic significance of β2-adrenergic receptor expression in non-small cell lung cancer." @default.
• W2593644105 cites W1485843004 @default.
• W2593644105 cites W1514373827 @default.
• W2593644105 cites W1701063005 @default.
• W2593644105 cites W1740332796 @default.
• W2593644105 cites W1882271490 @default.
• W2593644105 cites W1964932776 @default.
• W2593644105 cites W1975045288 @default.
• W2593644105 cites W1979538859 @default.
• W2593644105 cites W1979835088 @default.
• W2593644105 cites W1985385147 @default.
• W2593644105 cites W1993312546 @default.
• W2593644105 cites W1993432948 @default.
• W2593644105 cites W1999462166 @default.
• W2593644105 cites W2000253969 @default.
• W2593644105 cites W2009080196 @default.
• W2593644105 cites W2009811269 @default.
• W2593644105 cites W2011414865 @default.
• W2593644105 cites W2020961525 @default.
• W2593644105 cites W2022576341 @default.
• W2593644105 cites W2023766293 @default.
• W2593644105 cites W2024050621 @default.
• W2593644105 cites W2024309993 @default.
• W2593644105 cites W2028168755 @default.
• W2593644105 cites W2028933689 @default.
• W2593644105 cites W2034249705 @default.
• W2593644105 cites W2059135275 @default.
• W2593644105 cites W2063905766 @default.
• W2593644105 cites W2070039329 @default.
• W2593644105 cites W2074555738 @default.
• W2593644105 cites W2083364957 @default.
• W2593644105 cites W2104504726 @default.
• W2593644105 cites W2118147608 @default.
• W2593644105 cites W2133040355 @default.
• W2593644105 cites W2137374083 @default.
• W2593644105 cites W2139731996 @default.
• W2593644105 cites W2142094421 @default.
• W2593644105 cites W2147030008 @default.
• W2593644105 cites W2150926365 @default.
• W2593644105 cites W2151356556 @default.
• W2593644105 cites W2157201202 @default.
• W2593644105 cites W2161817637 @default.
• W2593644105 cites W2165157874 @default.
• W2593644105 cites W2169716624 @default.
• W2593644105 cites W2171399223 @default.
• W2593644105 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5126349" @default.
• W2593644105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27904707" @default.
• W2593644105 hasPublicationYear "2016" @default.
• W2593644105 type Work @default.
• W2593644105 sameAs 2593644105 @default.
• W2593644105 citedByCount "10" @default.
• W2593644105 countsByYear W25936441052018 @default.
• W2593644105 countsByYear W25936441052019 @default.
• W2593644105 countsByYear W25936441052020 @default.
• W2593644105 countsByYear W25936441052021 @default.
• W2593644105 countsByYear W25936441052022 @default.
• W2593644105 crossrefType "journal-article" @default.
• W2593644105 hasAuthorship W2593644105A5007784673 @default.
• W2593644105 hasAuthorship W2593644105A5017461232 @default.
• W2593644105 hasAuthorship W2593644105A5033780369 @default.
• W2593644105 hasAuthorship W2593644105A5053315729 @default.
• W2593644105 hasAuthorship W2593644105A5055462599 @default.
• W2593644105 hasAuthorship W2593644105A5062755674 @default.
• W2593644105 hasAuthorship W2593644105A5065203827 @default.
• W2593644105 hasAuthorship W2593644105A5078077911 @default.
• W2593644105 hasAuthorship W2593644105A5081222766 @default.
• W2593644105 hasAuthorship W2593644105A5085034288 @default.
• W2593644105 hasConcept C10205521 @default.
• W2593644105 hasConcept C121608353 @default.
• W2593644105 hasConcept C126322002 @default.
• W2593644105 hasConcept C142724271 @default.
• W2593644105 hasConcept C143998085 @default.
• W2593644105 hasConcept C146357865 @default.
• W2593644105 hasConcept C151730666 @default.
• W2593644105 hasConcept C204232928 @default.
• W2593644105 hasConcept C2776256026 @default.
• W2593644105 hasConcept C2779256057 @default.
• W2593644105 hasConcept C2781182431 @default.
• W2593644105 hasConcept C28328180 @default.
• W2593644105 hasConcept C54355233 @default.
• W2593644105 hasConcept C71924100 @default.
• W2593644105 hasConcept C86803240 @default.
• W2593644105 hasConcept C90924648 @default.
• W2593644105 hasConceptScore W2593644105C10205521 @default.

• next